Gynecomastia and hypertension in a patient treated with posaconazole

Gynecomastia and hypertension in a patient treated with posaconazole

Abstract Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.

Bibliographic Details
Main Authors: George R. Thompson III, Prasanth N. Surampudi, Alex Odermatt
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:Clinical Case Reports
Subjects:
11beta‐hydroxylase
adverse drug effect
estradiol
gynecomastia
hypertension
hypokalemia
Online Access:https://doi.org/10.1002/ccr3.3376

Similar Items

Similar Items